18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with131I

被引：2
|
作者：
Rosario, Pedro Weslley [1 ]
机构：
[1] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Rua Domingos Vieira 590, BR-30150240 Belo Horizonte, MG, Brazil
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 13期
关键词：
GUIDELINES;
D O I：
10.1007/s00259-020-05039-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
8
引用
收藏
页码：2950 / 2951
页数：2
相关论文
共 50 条
  • [21] 18F-FDG PET-CT in differentiated thyroid carcinoma with negative 131I post-therapy whole body scan and elevated TSH-stimulated thyroglobulin
    Salvatori, M.
    Mazza, R.
    Baldari, G.
    Basile, P.
    Maussier, M. L.
    Perotti, G.
    Giordano, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S266 - S266
  • [22] Role of 18F-FDG-PET/CT in thyroid carcinoma, after rec-TSH, with elevated human serum thyroglobulin and negative 131-I WBS: experience in 30 patients
    Biscontini, G
    Sara, R
    Possa, M
    Milella, M
    Oliverio, F
    Verini, M
    Superchi, M
    Monza, L
    Vigorelli, R
    Rossetti, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S327 - S327
  • [23] Role of Tl-201 whole-body scanning in differentiated thyroid cancer: Correlation with I-131 whole-body scanning and serum thyroglobulin
    Ryu, J
    Choi, Y
    Yang, S
    Lee, H
    Shong, Y
    RADIOLOGY, 1996, 201 : 1149 - 1149
  • [24] Investigating the role of F18-FDG PET/CT and Ga68 DOTATOC PET/CT in the evaluation of differentiated thyroid cancer patients with increased serum thyroglobulin and negative I-131 whole body scan
    Aghaee, A.
    Aryana, K.
    Esmatinia, M.
    Ravan, V. Roshan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S295 - S295
  • [25] Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I Scanning results after therapy
    Helal, BO
    Merlet, P
    Toubert, ME
    Franc, B
    Schvartz, C
    Gauthier-Koelesnikov, H
    Prigent, A
    Syrota, A
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (10) : 1464 - 1469
  • [26] Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy
    Laking, GR
    Price, PM
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (12) : 1728 - 1729
  • [27] Diagnostic accuracy of 18F-FDG PET in residual or recurrent differentiated thyroid carcinoma with high thyroglobulin and negative 131-I whole-body scan
    Martin, M. N. Cabrera
    Pingarron, J. A. Pasamontes
    Delgado, J. L. Carreras
    Gutierrez, Lapena
    Bolton, R. C. Delgado
    Copano, A. Bimni
    Castejon, M. J. Perez
    Perez, C. Fernandez
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2007, 26 (05): : 263 - 269
  • [28] Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas
    Giovanella, Luca
    Ceriani, Luca
    De Palma, Diego
    Suriano, Sergio
    Castellani, Massimo
    Verburg, Frederik A.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (05): : 626 - 631
  • [29] 18F-FDG PET/CT and ultrasonogrpahy in differentiated thyroid carcinoma patients with elevated serum levels of antithyroglobulin antibody, negative Tg and whole body 131I scan
    Liu, Jiao
    Liu, Baoping
    Yu, Yanxia
    Chao, Fangfang
    Liu, Yan
    Han, Xingmin
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2018, 21 (01): : 24 - 27
  • [30] Detection of Subcentimeter Metastatic Cervical Lymph Node by 18F-FDG PET/CT in Patients With Well-Differentiated Thyroid Carcinoma and High Serum Thyroglobulin But Negative 131I Whole-Body Scan
    Kunawudhi, Anchisa
    Pak-art, Rattaplee
    Keelawat, Somboon
    Tepmongkol, Supatporn
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : 561 - 567
12345